Group Projects Flashcards

1
Q

Antiphospholipid syndrome/hughes syndrome:

most common cardiac manifestations (5)

A
Valvular disease (mitral)
CAD
Intracardiac thrombus formation
Pulmonary HTN
Dialted cardiomyopathy
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Antiphospholipid syndrome/hughes syndrome:

Pharmaceutical therapies:

A
  1. antiplatelet and anticoagulation therapy combined

2. Warfarin with monitoring of INR (2-3)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Antiphospholipid syndrome/hughes syndrome:

APS patients are at risk for thrombosis so anticoagulation is imperative- what should you do

A

double ACT baseline or reach 2x normal value (960+)
us other anticoagulants (lepirudin, argatroban)
—ECMO and VAD patients must be on an anticoagulant

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Antiphospholipid syndrome/hughes syndrome:

if patients test positive for antiphospholipid antibodies, what should they do?

A

take aspirin due to risk of thrombosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Neonates and Premies:

causes of neonatal bleeding (4)

A
thrombocytopenia 
congenital factor deficiencies (Hemophilia A or B)
aquired deficiencies (Vit-K deficiency)
disseminated intravascular coagulation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Gravid Patient:

maternal BP is the most important determinant of what

A

uterine BF and fetal oxygenation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Gravid Patient:

increase in hemodynamic variables (CO, Blood vol, HR, stroke rate) all increase in what trimester

A

3rd

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Gravid Patient:

do they increase or decrease: clotting factors, protein C and S, PAI-1 and PAI-2

A
Increase- clotting factors 1, 2, 7, 8, 9, 12
shows resistance- protein C
decrease- protein S
increase- PAI-1
increase- PAI-2
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Gravid Patient:
alph-adrenergic agents should be…
drugs that exhibit combination of alpha and beta acticity are the most..

A

avoided

useful

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Vasoplegic Syndrome:

plasma proteins get absoebed into a biolayer on the walls of the ECC- they display receptors and activate what pathways?

A

contact system
Intrinsic coagulation
Extrinsic coagulation
Fibrinolysis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Vasoplegic Syndrome:

treatment

A
high doses of vasopressors post-op,
Nor-epi
dopamine
methylene blue
phenylephrine 
running hypothermia during the case
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Vasoplegic Syndrome:

what can be added to the prime in an effort to avoid this if the patient is high risk

A

methylene blue

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Vasoplegic Syndrome:

what can you do during the case if you suspect this

A

put methylene blue in the prime
don’t transfuse cardiotomy blood back to the patient
add volume
increase arterial pump flow

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Renal insufficiency:

what should you use for the prime and what do you do to prevent hemodilution

A

use saline instead of normal prime (add bicarb)

RAP and VAP to prevent hemodiltion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Renal insufficiency:

avoid what drugs

A
lepirudin
bivalirudin
warfarin
Nipride
Clonidine
Phentolamine
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Liver Failure:

what 2 things do you have to consider

A

impaired production of clotting factors

impairment of detoxification functions

17
Q

Liver Failure:
Drugs with first pass metabolism →
Drugs with high clearance →
Drugs with low clearance →

A

first pass metabolism → reduce in oral dose
high clearance → adjust loading and maintenance doses
low clearance → adjust maintenance dose

18
Q

HIPEC:

whats the duration

A

90 min

19
Q

NSAIDS:

name the selective NSAID

A

Celecoxin (Celebrex)

20
Q

NSAIDS:

MOA

A

act locally on tissues where protaglandins are synthesized by inhibiting the cyclooxygenase pathway

21
Q

Lipid Dyscrasias:

total cholesterol formula

A

LCL-C + VLDL-C + HDL-C

22
Q

Lipid Dyscrasias:

perfusion therapeutic modalities

A

AVOID STASIS
pre-op statin therapy
LDL apheresis

23
Q

Anermia:

sickle cell treatment before bypass

A
  • -Pre-op blood exchange

- -remove blood and separate plasma from cells and reinfuse plasma/platelets

24
Q

Anermia:

sickle cell treatment during bypass

A
maintain HCT above 24%
Prevent hypothermia (dont go below 33C)
Keep SvO2 over 80%
use crystalloid plegia instead of blood plegia
hemoconcentrate durin CPB
25
Q

Respiratory;

EVLP circuit usually contains

A

a reservoir, centrifugal pump, oxygenator/heat exchanger, leukocyte depleting filter and a flow meter

26
Q

Respiratory:

where is the lung cannulated

A

pulmonary artery (PA) and left atrial (LA) appendage